Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manohar Pradhan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Translational Oncology|December 6, 2016
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERGMaria P Silva, João D Barros-Silva, Elin Ersvær, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancerKristina Lindemann, Wanja Kildal, Andreas Kleppe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2025
Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapyKristina Lindemann, Wanja Kildal, Andreas Kleppe, et al.
Gynecologic Oncology|November 16, 2024
Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancerAndreas Kleppe, Kristina Lindemann, Wanja Kildal, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 6, 2019
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancerElin Ersvær, Wanja Kildal, Ljiljana Vlatkovic, et al.
Journal of the National Cancer Institute|April 24, 2018
Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological CancersBirgitte Nielsen, Andreas Kleppe, Tarjei Sveinsgjerd Hveem, et al.
British Journal of Cancer|April 29, 2016
Chromatin changes predict recurrence after radical prostatectomyTarjei S Hveem, Andreas Kleppe, Ljiljana Vlatkovic, et al.
British Journal of Cancer|July 3, 2024
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillanceKarolina Cyll, Erik Skaaheim Haug, Manohar Pradhan, et al.
British Journal of Cancer|June 16, 2017
Tumour heterogeneity poses a significant challenge to cancer biomarker researchKarolina Cyll, Elin Ersvær, Ljiljana Vlatkovic, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Translational Oncology|December 6, 2016
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERGMaria P Silva, João D Barros-Silva, Elin Ersvær, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancerKristina Lindemann, Wanja Kildal, Andreas Kleppe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2025
Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapyKristina Lindemann, Wanja Kildal, Andreas Kleppe, et al.
Gynecologic Oncology|November 16, 2024
Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancerAndreas Kleppe, Kristina Lindemann, Wanja Kildal, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 6, 2019
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancerElin Ersvær, Wanja Kildal, Ljiljana Vlatkovic, et al.
Journal of the National Cancer Institute|April 24, 2018
Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological CancersBirgitte Nielsen, Andreas Kleppe, Tarjei Sveinsgjerd Hveem, et al.
British Journal of Cancer|April 29, 2016
Chromatin changes predict recurrence after radical prostatectomyTarjei S Hveem, Andreas Kleppe, Ljiljana Vlatkovic, et al.
British Journal of Cancer|July 3, 2024
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillanceKarolina Cyll, Erik Skaaheim Haug, Manohar Pradhan, et al.
British Journal of Cancer|June 16, 2017
Tumour heterogeneity poses a significant challenge to cancer biomarker researchKarolina Cyll, Elin Ersvær, Ljiljana Vlatkovic, et al.
Pageof 4